What is dyssynergic defecation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Dyssynergic Defecation?

Dyssynergic defecation is a functional defecatory disorder characterized by paradoxical contraction or inadequate relaxation of the pelvic floor muscles during attempted defecation, resulting in impaired rectal evacuation despite adequate propulsive forces. 1

Core Pathophysiology

  • This is an acquired behavioral disorder where patients lose the ability to coordinate their abdominal and pelvic floor muscles to evacuate stool normally 2, 3
  • The pelvic floor muscles paradoxically contract rather than relax during straining, creating a functional obstruction at the anal outlet 4, 2
  • There are no associated morphological or neurological abnormalities—this is purely a coordination problem, not structural damage 5
  • The condition causes reduced rectal sensation and impaired awareness of the need to defecate due to chronic straining and pelvic floor dysfunction 4

Clinical Presentation: Key Features to Recognize

  • Prolonged excessive straining with soft stools is the hallmark clinical clue—if patients struggle to pass soft stool or cannot evacuate enema fluid, dyssynergic defecation should be strongly suspected 6
  • Sensation of incomplete evacuation after bowel movements 6, 3
  • Need for digital evacuation or perineal/vaginal pressure to facilitate defecation 1, 6
  • Sensation of anorectal blockage during attempted defecation 6
  • Inability to pass a water-filled balloon during balloon expulsion testing 1

Diagnostic Approach

Essential Tests

  • Anorectal manometry combined with balloon expulsion test is essential for diagnosis and should be performed first when defecatory disorder is suspected 1, 6
  • Digital rectal examination should assess pelvic floor motion during simulated evacuation, looking for paradoxical contraction or failure to relax the puborectalis muscle 6
  • High-resolution manometry and magnetic resonance defecography can provide additional mechanistic insights when needed 2, 7

When to Test

  • Test patients who fail initial conservative measures with fiber and laxatives 6
  • Test when clinical features suggest difficult evacuation: straining with soft stools, need for manual maneuvers, or sensation of blockage 1, 6
  • In cases of discordant anorectal manometry and balloon expulsion test results, consider fluoroscopic or magnetic resonance defecography to confirm pelvic floor dysfunction 1

Prevalence and Impact

  • Dyssynergic defecation affects up to one-half of patients with chronic constipation, making it one of the most common forms of functional constipation 2, 3
  • About one-third of chronically constipated patients have an evacuation disorder, with dyssynergic defecation being a common cause 3

First-Line Treatment: Biofeedback Therapy

  • Biofeedback therapy is the definitive first-line treatment with a Grade A recommendation, demonstrating superior efficacy to laxatives and other modalities 1
  • Success rates exceed 70-80% in clinical trials for patients with dyssynergic defecation 1, 2
  • The therapy trains patients to relax their pelvic floor muscles during straining and restores normal rectoanal coordination through operant conditioning principles 1
  • Treatment involves visual (computer monitor) or audible/verbal feedback to inform patients of muscle contraction strength and coordinated pressure changes during attempted defecation 1
  • Biofeedback is completely free of morbidity and safe for long-term use 4

Predictors of Treatment Success

  • Patients with lower or more normal baseline thresholds for first rectal sensation and urge are more likely to respond to biofeedback 1
  • Depression and elevated first rectal sensory threshold volume are independent predictors of poor biofeedback efficacy 1
  • Lower baseline constipation scores, shorter colonic transit times, and lower intolerable urgency thresholds predict better outcomes 1

Critical Pitfalls to Avoid

  • Do not continue escalating laxatives indefinitely in patients with defecatory disorders—this will not address the underlying pelvic floor dysfunction and delays definitive treatment 4
  • Do not assume constipation is purely a colonic motility problem; failure to recognize the pelvic floor component is a frequent reason for therapeutic failure 4
  • Do not skip anorectal testing in patients who fail initial conservative measures, as this is essential to identify the specific dysfunction 4
  • Do not attribute bowel symptoms solely to irritable bowel syndrome without first excluding a defecatory disorder 6

Alternative Treatment Options

  • Sacral nerve stimulation may improve rectal sensation in patients with rectal hyposensitivity when biofeedback fails or is unavailable 4
  • Botulinum toxin type A injection has been studied but evidence is poor with heterogeneous outcomes (symptomatic improvement ranging from 29.2% to 100%) and should not be considered first-line 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and Treatment of Dyssynergic Defecation.

Journal of neurogastroenterology and motility, 2016

Research

Dyssynergic Defecation: A Comprehensive Review on Diagnosis and Management.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2023

Guideline

Recovery of Pelvic Floor Function

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Biofeedback therapy for dyssynergic defecation.

World journal of gastroenterology, 2006

Guideline

Constipation Assessment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Botulinum toxin type A for the treatment of dyssynergic defaecation in adults: a systematic review.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2020

Related Questions

What is causing an elderly female's hard, pebble-like stools and frequent small bowel movements (BM) daily, despite a daily regimen of fiber, water, magnesium citrate, and probiotic?
What is the medical term for painful bowel movements?
How should I evaluate and manage a patient with functional (dyssynergic) defecation who meets Rome IV criteria, has no alarm features, and demonstrates impaired pelvic‑floor coordination?
What is causing incomplete evacuation of the bowel in a patient with a history of soft stools and previous PEG (Percutaneous Endoscopic Gastrostomy) use?
What is the recommended treatment for dyssynergic defecation, specifically the role of biofeedback therapy?
What is the appropriate evaluation and management for acute right testicular pain with swelling?
What is the appropriate next antihypertensive management for a 71‑year‑old man with stage‑2 hypertension (blood pressure 155/86 mm Hg) who is currently taking metoprolol 25 mg daily?
Can a psychiatric mental‑health provider with prescriptive authority legally prescribe vitamin D for an adult patient with documented 25‑hydroxyvitamin D deficiency and depression?
What is the recommended treatment regimen for scabies, including first‑line therapy, alternatives for infants, pregnant or lactating women, and management of crusted scabies?
Does a positive respiratory culture for Mycobacterium chimaera (a Mycobacterium avium complex organism) require treatment in an asymptomatic patient without radiographic disease or risk factors?
What are the evidence‑based treatment options for an adult presenting with problematic anger, including psychotherapy and pharmacologic therapies?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.